Welcome
Support Centre
02 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Post-Operative Radiotherapy for Selected High Risk Rectal Adenocarcinoma
ISRCTN ISRCTN91411631
ClinicalTrials.gov identifier
Public title Post-Operative Radiotherapy for Selected High Risk Rectal Adenocarcinoma
Scientific title
Acronym N/A
Serial number at source GI/HRR
Study hypothesis Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Colorectal cancer
Participants - inclusion criteria 1. Histologically proven adenocarcinoma of the rectum
2. Surgery at or below pelvic brim
3. Curative operation, all macroscopic disease removed
4. Aged <80 years, 75 years if physically unfit
5. No previous history of multiple abdominal or pelvic surgical procedures
6. No evidence of small bowel descending into area of maximum dose of radiotherapy
7. Adequate bone marrow function
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/01/2000
Anticipated end date 31/12/2005
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Following surgery patients are randomised to one of two treatment arms:
1. Arm A: Post-operative radiotherapy, a midplane dose of 45 Gy given over 4 to 5 weeks
2. Arm B: No radiotherapy
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Northern and Yorkshire Clinical Trials and Research Unit (UK)
Trial website
Publications
Contact name Dr  -  -
  Address UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Tel +44 (0) 20 7670 4723
  Fax +44 (0) 20 7670 4818
  Email register@ctu.mrc.ac.uk
Sponsor Northern and Yorkshire Clinical Trials and Research Unit (UK)
  Address -
  City/town Leeds
  Zip/Postcode -
  Country United Kingdom
Date applied 19/08/2002
Last edited 20/05/2008
Date ISRCTN assigned 19/08/2002
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central